The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Abstract
Emerging evidence implicates a role of the gut microbiota in colorectal cancer (CRC). Peptostreptococcus anaerobius (P. anaerobius) is an anaerobic bacterium selectively enriched in the faecal and mucosal microbiota from patients with CRC, but its causative role and molecular mechanism in promoting tumorigenesis remain unestablished. We demonstrate that P. anaerobius adheres to the CRC mucosa and accelerates CRC development in Apc Min/+ mice. In vitro assays and transmission electron microscopy revealed that P. anaerobius selectively adheres to CRC cell lines (HT-29 and Caco-2) compared to normal colonic epithelial cells (NCM460). We identified a P. anaerobius surface protein, putative cell wall binding repeat 2 (PCWBR2), which directly interacts with colonic cell lines via α 2/β 1 integrin, a receptor frequently overexpressed in human CRC tumours and cell lines. Interaction between PCWBR2 and integrin α 2/β 1 induces the activation of the PI3K-Akt pathway in CRC cells via phospho-focal adhesion kinase, leading to increased cell proliferation and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. NF-κB in turn triggers a pro-inflammatory response as indicated by increased levels of cytokines, such as interleukin-10 and interferon-γ in the tumours of P. anaerobius-treated Apc Min/+ mice. Analyses of tumour-infiltrating immune cell populations in P. anaerobius-treated Apc Min/+ mice revealed significant expansion of myeloid-derived suppressor cells, tumour-associated macrophages and granulocytic tumour-associated neutrophils, which are associated with chronic inflammation and tumour progression. Blockade of integrin α 2/β 1 by RGDS peptide, small interfering RNA or antibodies all impair P. anaerobius attachment and abolish P. anaerobius-mediated oncogenic response in vitro and in vivo. Collectively, we show that P. anaerobius drives CRC via a PCWBR2-integrin α 2/β 1-PI3K-Akt-NF-κB signalling axis and identify the PCWBR2-integrin α 2/β 1 axis as a potential therapeutic target for CRC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some members of this signature, such as F. nucleatum and P. anaerobius, have been shown to promote colorectal carcinogenesis and modulate tumour immunity74,75”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [75]
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
Humphries, J. D., Byron, A., & Humphries, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03098 · Cited by 1,711
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375
Cited by
Sorted by citations
Items 301–400 of 565
Chang, Y., Ou, Q., Zhou, C., Liu, J., & Zhang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1182006 · Cited by 10
“, 2022); and finally, it changes the tumor microenvironment and promotes tumor immunosuppression (Kostic et al., 2013; Long et al., 2019).”
BackgroundMicrobiome and colorectal cancer: A review of the past, present, and future
Johns, M. S., & Petrelli, N. J. (2021) · Surgical Oncology · doi:10.1016/j.suronc.2021.101560 · Cited by 9
Comparison of changes in fecal microbiota of calves with and without dam
Li, M., Wang, Z., Wang, L., Bai, X., Hu, R., Zou, H., Liu, S., Shah, A. M., & Peng, Q. (2022) · PeerJ · doi:10.7717/peerj.12826 · Cited by 9
“The genera Peptostreptococcus have shown to promotes colorectal carcinogenesis and may play a carcinogenic role through direct interaction with colonic epithelial cells (Long et al., 2019).”
BackgroundSakai, S. A., Aoshima, M., Sawada, K., Horasawa, S., Yoshikawa, A., Fujisawa, T., Kadowaki, S., Denda, T., Matsuhashi, N., Yasui, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.925444 · Cited by 9
“In patients with CRC, several pathogenic bac t e r i a , su ch a s Fu sobac t e r ium nuc l ea tum and Peptostreptococcus anaerobius, promote carcinogenesis by physically interacting with the tumor (Long et al., 2019; Ternes et al., 2020; Inamori et al., 2021).”
BackgroundLiu, Q., He, M., Zeng, Z., Huang, X., Fang, S., Zhao, Y., Ke, S., Wu, J., Zhou, Y., Xiong, X., et al. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14245 · Cited by 8
“Dysbiosis of the gut microbiota connects with various diseases, such as obesity (Liu et al., 2017; Turnbaugh et al., 2006), insulin resistance (Pedersen et al., 2016) and colorectal cancer (Long et al., 2019).”
BackgroundPeptostreptococcus anaerobius is a potential diagnostic biomarker of colorectal cancer
Zhang, Y., Fan, K., Li, L., He, J., & Sun, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.10.36 · Cited by 8
“The latest study demonstrated that intestinal epithelial cells can absorb P.a and further trigger the growth of CRC through regulating local immunity (11).”
Third-generation PacBio sequencing to explore gut bacteria and gender in colorectal cancer
Yu, S., Chu, J., Wu, Y., Jing, Z., Qu, Z., Song, Y., Wu, X., & Han, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106684 · Cited by 8
Microbiota-associated mechanisms in colorectal cancer
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.05.002 · Cited by 8
Markiewicz, L. H., Ogrodowczyk, A. M., Wiczkowski, W., & Wróblewska, B. (2022) · Nutrients · doi:10.3390/nu14204234 · Cited by 8
“7) and was similar to the routinely applied one [10].”
ResultWei, P., Wu, M., Huang, C., Ho, Y.-H., Hung, C.-S., Lin, Y., Tsao, M.-F., & Lin, J.-C. (2022) · Biomedicines · doi:10.3390/biomedicines10071741 · Cited by 8
“Peptostreptococcus anaerobius exhibits the activity on activating the PCWBR2-integrin a2/b1-PI3K-Akt-NFkB axis throughout CRC occurrence, which was considered a potential therapeutic target toward CRC [9].”
BackgroundMicrobiome‐driven anticancer therapy: A step forward from natural products
Guan, Y., Wu, D., Wang, H., & Liu, N. (2024) · mLife · doi:10.1002/mlf2.12118 · Cited by 7
“For instance, pathogenic bacteria, including Clostridium perfringens, Anaerobes , and Klebsiella pneumoniae , can induce in fi ltration of M2 ‐ like TAMs, thereby promoting the growth and metastasis of CRC 49 – 51 .”
BackgroundWu, Y., Shen, N., Hope, C., Noh, H. I., Richardson, B. N., Swartz, M. C., & Bai, J. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00026 · Cited by 10
Xu, X., Xiong, S., Du, T., Li, J., Zhao, M., Zhao, M., Huang, T., Ren, H., Xiong, T., & Xie, M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105569 · Cited by 8
Immunomodulatory Effects of Flavonoids in Colitis-Associated Colorectal Cancer
Navia, S. E. H., Vega, L., Rodríguez, T., & Rodríguez‐Sosa, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041883 · Cited by 7
Setting higher standards for reports of microbial species in human cancers
Salzberg, S. L., Chia, M., Tay, C. Y., de Miranda, N. F. C. C., Smit, V. T. H. B. M., Wesseling, J., Irizarry, R. A., Marshall, B. J., Willerslev, E., Neefjes, J., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01121-6 · Cited by 8
Pekel, S., Karcher, N., Essex, M., Springer, F., Romano, S., Ducarmon, Q. R., Schudoma, C., Larralde, M., Lupatin, A., Zeißig, S., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.030 · Cited by 10
Intratumoral microbiome and gastrointestinal cancers
Li, S., Li, Q., & Lu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1047015 · Cited by 7
“While PI3K-Akt pathway activated in CRC can lead to increased cell proliferation and NF-kB activation (58).”
BackgroundDu, Y., Wang, Q., Zheng, Z., Zhou, H., Han, Y., Qi, A., Jiao, L., & Gong, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1425802 · Cited by 7
“…bacteria such as Fusobacterium nucleatum and Peptostreptococcus anaerobius in the intestinal epithelium, playing an important role in carcinogenesis by inducing tumor proliferation (62), enhancing inflammation (63), triggering DNA damage (64) and provide protection to tumor from immune attack (65).”
BackgroundLengyel, M., Molnár, Á., Nagy, T. M., Jdeed, S., Garai, I., Horváth, Z., & Uray, I. P. (2024) · Cancer Science · doi:10.1111/cas.16382 · Cited by 7
Hong, G., Li, Y., Yang, M. J., Li, G., Jin, Y. T., Xiong, H., Qian, W., & Hou, X. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2136013 · Cited by 8
“Peptostreptococcus was reported to contribute to colorectal cancer via a PCWBR2-integrin a2/b1-PI3KAkt-NF-jB signal axis [38] and correlate positively with UC activity [39], and Ruminococcus gnavus could produce an inflammatory polysaccharide to aggravate colitis [40].”
BackgroundHuang, Z., Chang, Y., Hao, K., Tan, Y., Ding, L., Wang, L., Wang, Z., Pan, Z., Gao, H., Wu, J., et al. (2023) · iMeta · doi:10.1002/imt2.100 · Cited by 7
Does postcholecystectomy increase the risk of colorectal cancer?
Dong, Z., Shi, R., Li, P., Song, X., Dong, F., Zhu, J., Wu, R., Liang, Z., Du, M., Wang, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1194419 · Cited by 8
“NF-κB, in turn, triggers a pro-inflammatory response as indicated by increased levels of cytokines (Long et al., 2019).”
BackgroundGonzález, A., Fullaondo, A., Navarro, D., Rodríguez, J., Tîrnȃucȃ, C., & Odriozola, A. (2024) · Cancers · doi:10.3390/cancers16234008 · Cited by 6
Recent Advances in Nanomedicine for Modulating Intratumoral Bacteria in Cancer Therapy
Zhang, Y., Zhang, H., Xu, J., Xu, Z., Lou, J., Zheng, Q., Yuan, S., Zhu, L., & Xu, X. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00677 · Cited by 7
RETRACTED: Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis
Ullah, S., Wu, C., Zou, X., Zhong, Y., Ahmad, A., Jan, A. U., Cong, Y., Chen, Y., & Li, L. (2025) · iScience · doi:10.1016/j.isci.2025.113945 · Cited by 8
“13 In addition, P. anaerobius suppresses anti-tumor immunity by activating the integrin α 2 β 1-NF-κ B axis, which induces CXCL1 secretion and recruits CXCR2+ myeloid-derived suppressor cells (MDSCs), facilitating immune evasion and disease progression.”
RetractedContextualizing TH17 cells in cancer
Pang, D., Bertocchi, A., Powrie, F. M., & Pohin, M. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01250-6 · Cited by 7
Dutta, G., Mishra, P., Mishra, S. P., & Badhai, J. (2026) · Onco · doi:10.3390/onco6030031 · Cited by 7
“…, Enterococcus faecalis , Streptococcus gallolyticus , and certain toxigenic Clostridium species, have been implicated in oxidative stress, epithelial barrier disruption, altered cholesterol and polyamine metabolism, immune dysregulation, and tumor-promoting inflammatory signaling [213–215].”
Popov, J., Caputi, V., Nandeesha, N., Rodriguez, D. A., & Pai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111365 · Cited by 12
“This leads to downstream activation of the NF-κB pathway, a key regulator of intestinal inflammation and cancer development and progression [172].”
BackgroundFXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy
Yu, D., Lu, Z., Wang, R., Xiang, Y., Li, H., Lu, J., Zhang, L., Chen, H., Li, W., Luan, X., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115570 · Cited by 7
Su, S., Bu, Q., Bai, X., Huang, Y., Wang, F., Hong, J., Fang, J., Wu, S., & Sheng, C. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106586 · Cited by 6
Yuan, X., Lau, H., Huang, H., Hsueh, C., Gong, H., & Zhou, L. F. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001221 · Cited by 6
“The pro-tumorigenic effect of bacteria via the PI3K-Akt pathway in CRC has been reported [22].”
BackgroundMicrobiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 7
Li, B., Li, P., Xia, W., You, B., Yu, Q., Zhang, B., Huang, R., Wang, R., Liu, Y., Chen, Z., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3194 · Cited by 6
“The cytoplasmic part of integrin α2β1 is the center for focal adhesion (FA) (9) assembly, with the assembling partners including the Src family kinase (SFK), focal adhesion kinase (FAK) and integrin-linked kinase (ILK) of which the modifications may affect biological processes (4,10,11).”
BackgroundMicrobiome and the Hallmarks of Cancer
Bleich, R. M., & Arthur, J. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_1 · Cited by 8
Advances in Organoid Culture Research
Xie, Z., Wang, L., & Zhang, Y. (2022) · Global Medical Genetics · doi:10.1055/s-0042-1756662 · Cited by 9
Vaccination and Microbiota Manipulation Approaches for Colon Cancer Prevention in Rodent Models
Tosti, E., Srivastava, N., & Edelmann, W. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-23-0015 · Cited by 6
Role of Crosstalk Between Gut Microbiota and Immune Cells in Colorectal Cancer: A Narrative Review
Ye, M., Yuan, G., Jin, Y., & Zeng, X. (2025) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000172 · Cited by 5
Lin, L., Li, W., Yan, L., Guo, X., Zhuang, M., Chen, F., & Ye, W. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03926-4 · Cited by 5
“Furthermore, Peptostreptococcus anaerobius has been implicated in the promotion of colorectal carcinogenesis and the modulation of tumor immunity [32].”
Characteristic metabolite profile of 10 colorectal cancer-related bacteria
Liu, Y., Mei, W., Huang, X., Yao, X., Kong, C., & Chen, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1604876 · Cited by 5
New advances in oral microbiology and tumor research
Liang, H.-J., Tan, X., Li, D., Lin, C., Suo-yi, H., Nie, G.-C., Guo, X., Zhang, Z.-B., Zhu, X., & Tan, S. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i7.106981 · Cited by 5
Hemati, S., Abdolalipour, E., Emadi, A., Ghadiri-Asli, S.-A., Aghababa, A. A., Sanami, S., Naderian, R., Mahooti, M., & Zare, D. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107400 · Cited by 5
Wang, J., Su, Z., Zhang, X., Wang, S., Chen, X., Xu, X., He, B., & Zheng, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123915 · Cited by 5
Gut microbiota drives cancer evolution and therapy resistance
Min, S., Zhang, Y., Zhang, H., & Liu, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02564-8 · Cited by 8
Yao, Q., Chen, S., Qian, W., Yang, C., & Li, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1724908 · Cited by 5
Cao, Y., Wang, J., Wang, H., Sun, X., Fang, F., Li, S., Liu, J., Shi, C., Qi, P., Zou, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202516272 · Cited by 5
“Previous studies have linked gut microbiota to the malignant progression of CRC [ 39, 40 ].”
Yang, X., Zhang, K., Xia, L., & Li, J. (2026) · iMetaMed · doi:10.1002/imm3.70030 · Cited by 5
Ren, X., Zheng, G., Liu, Y., Li, S., Liu, S., Wen, Y., Zhang, Y., Zhao, Y., Guan, H., Wang, X., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.01.020 · Cited by 6
Gut microbiome in colorectal cancer: recent advances and clinical implications
Han, J. Y., Kim, M. J., Park, J. W., & Jeong, S. (2026) · Annals of Coloproctology · doi:10.3393/ac.2026.00010.0001 · Cited by 5
“Pa directly amplifies inflammatory signals within the tumor microenvironment [29].”
Zhang, J., Chen, X., Zou, J., Li, C., Kang, W., Guo, Y., Liu, S., Zhao, W., Mou, X., Huang, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02116-22 · Cited by 5
Wen, X., Ye, X., Yang, X., RuJin, J., Qian, C., & Wang, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02995-5 · Cited by 5
“Increasing the expression of pro-inflammatory cytokines and recruiting immunosuppressive myeloid-derived suppressor cells [131]”
BackgroundIntestinal Microbiomics in Physiological and Pathological Conditions
Ionescu, R. F., Cozma, E. C., Enache, R. M., Creţoiu, S. M., Iancu, M., Mandea, M., Profir, M., Roşu, O. A., & Gașpar, B. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110642 · Cited by 5
Mapping the pancancer metastasis tumor microbiome
Wong, C. C., & Yu, J. (2024) · Cell · doi:10.1016/j.cell.2024.03.040 · Cited by 5
Self-citationpks+ E. coli adhesins—The fine line between good and evil
Wong, C. C., & Yu, J. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2024.12.007 · Cited by 5
Self-citationPersonalized nutrition for colorectal cancer
Wang, K., & Song, M. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.004 · Cited by 5
Chai, C., Tang, X., Chi, X., Li, X., Zhang, H., & Wu, L. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111053 · Cited by 5
Microbiota, mucosal immunity, and Colon cancer
Drewes, J. L., Domingue, J. C., & Housseau, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00008-8 · Cited by 5
Gong, Y. (2025) · American Journal of Cancer Research · doi:10.62347/dyun7645 · Cited by 4
Zhang, J., Wei, Z., & Fan, G. (2025) · Foods · doi:10.3390/foods14173040 · Cited by 4
“This strain can also increase the expression of proinflammatory cytokines and recruit tumor-infiltrating immune cells, aiding in establishing a microenvironment favorable for tumor initiation [49].”
Shekar, P. K., Pradeep, S., Shivamallu, C., Prashant, A., & Vishwanath, P. M. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04197-1 · Cited by 4
“For instance, Fusobacterium nucleatum and Peptostreptococcus anaerobius promote the differentiation of M2-like TAMs via TLR engagement and STAT3 activation, fostering an immunosuppressive phenotype [15, 25].”
Yang, Z., Peng, C., Iwan, M. A., Chen, L., He, M., Zhang, Z., Chen, Y., Tang, J., Wang, J., Liu, Y., et al. (2024) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2024.113540 · Cited by 4
Bai, S., Zhang, P., Qi, X., Liu, J., Liu, D., Wang, G., Pang, L., & Li, S. (2024) · Water Biology and Security · doi:10.1016/j.watbs.2024.100288 · Cited by 4
Kiouri, D. P., Batsis, G., Mavromoustakos, T., Giuliani, A., & Chasapis, C. T. (2025) · BioTech · doi:10.3390/biotech14010013 · Cited by 4
“Finally, based on the plot that associates the degree of the human proteins that participate in the host–gut interplay versus in the human interactome (Figure 8), there appears to be a non-significant correlation between the two.”
Zhu, Y., Zeng, X., Zhang, A., Lü, B., Wu, M., Liu, H., Zhu, F., & Lin, R. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2488054 · Cited by 4
Molecular Mechanisms of Gut Microbiota-Associated Colorectal Carcinogenesis
Shao, Y., & Zeng, X. (2020) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000030 · Cited by 4
“When the PI3K–Akt pathway in CRC cells is activated, tumor cell proliferation and NF-kB activation are subsequently triggered, which provoke a pro-inflammatory immune microenvironment-favor tumor growth.(68)”
BackgroundCell-Based Immunotherapy Approaches for Colorectal Cancer: Main Achievements and Challenges
Shahnazari, M., Samadi, P., Pourjafar, M., & Jalali, A. (2021) · Future Oncology · doi:10.2217/fon-2020-1218 · Cited by 4
Chang, Y., Li, X., Ding, L., Yang, C., Pan, Z., Han, N., Cui, Y., Zhi, F., Yang, R., Gao, H., et al. (2021) · Engineering · doi:10.1016/j.eng.2021.03.028 · Cited by 4
Recent progress in gut microbiota
Cheng, D., & Xing, H. (2023) · Gastroenterology & Endoscopy · doi:10.1016/j.gande.2022.11.001 · Cited by 4
Yu, J., Nong, C., Zhao, J., Meng, L., & Song, J. (2022) · Disease Markers · doi:10.1155/2022/7994074 · Cited by 4
“Fusobacterium nucleatum and anaerobic streptococci can promote the occurrence, development, and treatment of colorectal tumors [3, 4]; probiotics such as lactobacilli can inhibit the occurrence and development of colorectal tumors and can improve postoperative indicators and reduce complications in patients with color…”
BackgroundSelf-citationDiet, microbes, and cancer across the tree of life: a systematic reviewPreprint
Kapsetaki, S. E., Alcaraz, G. M., Maley, C. C., Whisner, C. M., & Aktipis, A. (2021) · Research Square · doi:10.21203/rs.3.rs-1077771/v1 · Cited by 4
Evolutionary plasticity of bacterial surface layer protein exoskeletonsPreprint
Barwinska‐Sendra, A., Salgado, P. S., & Sendra, K. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.02.646754 · Cited by 4
Chen, S., Li, Y., Liu, J., Wu, J., Zhao, H., Cao, R., & Zhou, S. (2025) · BioFactors · doi:10.1002/biof.70038 · Cited by 3
“Peptostreptococcus anaerobius induces pyroptosis through a “Yersinia infection”-like pathway, damaging intestinal barriers [39].”
Xiao, P., Li, C., Liu, Y., Zhong, J., Cui, X.-L., Liu, C., & Yang, W. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i34.109825 · Cited by 3
“The pathogenesis of CRC is complex and diverse, involving abnormal regulation of multiple signaling pathways, including the Wnt/ β -catenin pathway[4,5], epidermal growth factor receptor (EGFR) pathway[6,7], transforming growth factor beta pathway and nuclear factor kappa B (NF-κB) pathway[8-10].”
Yang, Z., Luo, K., Chen, D. W., Dou, L., Huang, X., & Kan, J. (2025) · Foods · doi:10.3390/foods14183278 · Cited by 3
“Existing studies have fully confirmed that signaling pathways such as PI3K-AKT play a core regulatory role in tumorigenesis and development [54].”
Bacteria modulate tumor-associated macrophages to combat cancer
Chen, Z., Li, J., Wang, J. J., Bai, Y., Zhang, Z., Chen, G., Cao, X. T., & Jin, D. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104983 · Cited by 3
Yuan, Q., Sun, Y., Zhang, Y., Chen, C., Bu, C., Hua, X., Sun, L., Sun, Y., Zhang, Z., & Feng, Y. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-3400 · Cited by 4
Zhang, W., Su, Q., Shi, H., Sun, Y., Li, X., Li, M., Wang, H. M., Yu, J., Wong, N., Chan, F. K. L., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07886-9 · Cited by 3
“The multiplicity of infection (MOI) = 100 was selected based on previous studies [26–28] investigating host-bacteria interactions in colorectal cancer models in vitro, where this ratio has been widely applied to examine bacterial effects on epithelial and tumor cells.”
Self-citationThe human microbiome at translational crossroads: an ecological and causal perspective
Wong, S. H. (2026) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2026-102 · Cited by 3
“[37,38] Despite these mechanistic links, recent quantitative profiling studies have identified important confounders.”
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
Chen, J., Bai, Y., Shen, L., Ying, J., Xu, J. Q., Tang, J., & Bao, Y.-J. (2026) · MedComm · doi:10.1002/mco2.70825 · Cited by 3
“In CRC, Peptostreptococcus anaerobius promotes carcinogenesis through its surface protein PCWBR2, which binds integrin α 2/ β 1 on tumor cells and activates the PI3K-Akt-NF-κ B signaling cascade [ 212 ].”
Zhang, H., Liu, W., Zhang, Y., 陈舒晨, & Sun, G. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1840613 · Cited by 4
“They can release chemotactic and immunoregulatory signals that promote the recruitment, retention, and functional maintenance of M-MDSCs (Yang et al., 2024a; Long et al., 2019; Hu et al., 2026a).”
Gut microbiota in health and disease
Li, Y. N., Xiao, X., Jiang, X., Li, X., WANG, W., & Lin, R. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00512-6 · Cited by 6
“…micra activates the miR-218-5p/RAS (rat sarcoma viral oncogene)/ERK (extracellular signal-regulated kinase)/c-Fos axis [159], whereas Peptostreptococcus anaerobius stimulates PI3K/AKT signaling through integrin α2β1 binding mediated by its PCWBR2 (putative cell wall binding repeat 2) protein [160].”
Robust prediction of colorectal cancer via gut microbiome 16S rRNA sequencing data
Porreca, A., Ibrahimi, E., Maturo, F., Marcos-Zambrano, L. J., Meto, M., & Lopes, M. B. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001903 · Cited by 3
Deciphering Gut Microbiome in Colorectal Cancer via Robust Learning Methods
Han, H., Li, Y., Qi, Y., Mangiola, S., & Ling, W. (2025) · Genes · doi:10.3390/genes16040452 · Cited by 4
“Studies in animal models have demonstrated that P. anaerobius adheres to colorectal mucosa and modulates tumor immunity, creating a microenvironment that favors tumor growth [49,50].”
Wang, C., Chen, Q., Tang, M., Wei, T., & Zou, J. (2023) · Journal of Fish Diseases · doi:10.1111/jfd.13744 · Cited by 3
Zhen, J., Liu, C., Liao, F., Zhang, J., Xie, H., Tan, C., & Dong, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1169369 · Cited by 4
“Additionally, some types of microbiota could also provoke a pro-inflammatory environment by activating the NF-kB pathway and increasing the expressions of pro-inflammatory cytokines (62, 63).”
BackgroundGut microbiota: key facilitator in metastasis of colorectal cancer
Yu, S., Wang, S., Xiong, B., & Peng, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1270991 · Cited by 5
“Certain speci fi c pathogens such as F. nucleatum and P. anaerobius can induce tumor-derived chemokine CXCL1 to recruit the MDSCs, thereby suppressing anti-tumor immunity (61, 107).”
InfluentialGut microbial subtypes and clinicopathological value for colorectal cancer
Han, S., Jing, Z., Song, Y., Wu, X., Yu, X., Ye, T., Chu, J., Qu, Z., Wu, Y., Han, S., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70180 · Cited by 3
“…obligate anaerobes can disrupt gut microbiota homeostasis and ultimately accelerate the occurrence and progression of chronic inflammation and CRC. 33 In this study, the content of anaerobic bacteria was negatively correlated with subtype B, while faculta-tive anaerobic bacteria contents were…”
BackgroundYuan, Z., Hong, J., Khan, J., Lu, J.-Q., Sanogo, B., Wu, Z., Sun, X., & Lin, D. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012828 · Cited by 3
Microbiome in Human Gastrointestinal Cancers
Coker, O. O., & Yu, J. Q. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_2 · Cited by 2
Self-citationGut Microbiota Impacts on the Efficacy of Anticancer Treatment of Colorectal Cancer
Hong, J., & Fang, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_15 · Cited by 3
Cekikj, M., Jakimovska, M., Kalajdzhiski, S., Özcan, O., & Sezerman, O. U. (2022) · Applied Sciences · doi:10.3390/app12094094 · Cited by 4
“Nowadays, numerous studies have verified that gut microbiota can alter CRC susceptibility and progression since the gut microbiota can have an impact on colorectal carcinogenesis by inducing tumor proliferation [6,7], inducing newly developed adenoma, promoting inflammation [8], and causing DNA damage [9].”
BackgroundSynbiotics in the Management of Breast Cancer
Thekkekkara, D., Manjula, S. N., Mishra, N., Bhatt, S., & Shilpi, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-7550-9_14 · Cited by 3
Evolving pinna-like surfaces for a biomimetic sonar head
Kampchen, N. (2000) · Cited by 3
Advances in Probiotics for Health and Nutrition
Zambare, V., Din, M. F. M., Gupta, P., & Prajapati, B. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104299 · Cited by 2
Al-Matouq, J. A., Hawra, A., Alibrahim, N., Alsaffar, N., Radwan, Z. H., & Ali, M. D. (2025) · Cancers · doi:10.3390/cancers17020226 · Cited by 3
Cultrera, G., Franco, S., Spoto, G., Libra, M., & Falzone, L. (2025) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2025059551 · Cited by 2
Liu, X., Mao, W., Zhao, G., Liao, J., Li, Q., & He, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1588399 · Cited by 2
“Specific pathogens, such as Fusobacterium nucleatum , anaerobic Streptococcus , and enterotoxin-producing Bacteroides fragilis , have been shown to promote CRC development through mechanisms including tumor proliferation, inflammation, DNA damage, and immune evasion (19, 20).”
Characteristics of gut microbiota in high-methylated colorectal cancer
Saito, T., Karasawa, H., Ouchi, K., Ono, T., Kajiwara, T., Kohyama, A., Ikeda‐Ohtsubo, W., Fukuda, S., Fujishima, F., Ozawa, Y., et al. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02812-3 · Cited by 2
“F. nucleatum and Peptostreptococcus anaerobius play key roles in CRC development by adhering to mucosal cells through specialized membrane proteins [43, 44].”
Gopalakrishnan, V., Saravanan, V., Mahendran, M. I. M. S., Boopathy, V., Vaithianathan, R., Srinivasan, S., & Krishnamurthy, S. (2025) · Apmis · doi:10.1111/apm.70041 · Cited by 2
“P . anaerobius causes CRC through the PCWBR2-integrin α2/β1-PI3K–Akt– NF-κB signaling axis and points to the PCWBR2-integrin α2/ β1 axis as a possible target for CRC treatment [13].”
InfluentialMa, L., Wang, W., Ma, S., Wang, Y., Hai, L., Gao, Y., & Xie, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1742672 · Cited by 2
“After antibiotic treatment to eliminate endogenous microorganisms in APCMin/+ mice, continuous oral gavage of P. stomatis or P. anaerobius signi fi cantly increased the incidence of high-grade dysplasia, adenomas, and adenocarcinomas in the colorectum (Long et al., 2019).”
Zhang, Y., Zhang, B., Pang, W., Gu, W., Wang, X., Yuan, H., Fang, S., Zhang, J., Li, X., Xing, X., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02378-w · Cited by 2
“The following primers were used: F. nucleatum , forward 5 ′ -CTG TAT TGC GTT GGA AAC TGT GTA A-3 ′ and reverse 5 ′ -TAC CAG GGT ATC TAA TCC TGT TTG C-3 ′ ; P. anaerobius , forward 5 ′ -AGA CGA ATT CAA GTC AGT AAA TAC A-3 ′ and reverse 5 ′ -CTC CTA TCC ACC AGG ATA TCA A-3 ′ [38].”
Influential
Metadata
- Authors
- Long, X., Wong, C. C., Tong, L., Chu, E. S. H., Ho Szeto, C., Go, M. Y. Y., Coker, O. O., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., & Yu, J.
- Affiliations
- Chinese University of Hong Kong (HK)
- Corresponding author
- Yu, Jun
- ORCID
- Venue
- Nature Microbiology
- Published
- 2019-09-09
- Volume
- 4
- Issue
- 12
- Pages
- 2319-2330
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W2972734154
- Cited by
- 557
- References
- 34
- Citations by year
- 2026: 88 · 2025: 101 · 2024: 87 · 2023: 112 · 2022: 72 · 2021: 64 · 2020: 31
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Peptostreptococcus anaerobius, colorectal cancer, colorectal carcinogenesis, gut microbiota, bacterial adhesion, PI3K/Akt signaling, NF-κB, focal adhesion kinase, tumour immunity, myeloid-derived suppressor cells, tumour-associated macrophages, tumor-associated neutrophils, chronic inflammation, ApcMin/+ mice, RGDS peptide, therapeutic target, tumor microenvironment
- MeSH terms
- Animals, Biotin, Cell Survival, Colon, Disease Models, Animal, Humans, Male, Mice, Inbred C57BL, Peptostreptococcus, Colorectal Neoplasms, Signal Transduction, Cytokines, NF-kappa B, Caco-2 Cells, HT29 Cells, Phosphatidylinositol 3-Kinases, Gene Expression Profiling, Integrin alpha2beta1, Cell Proliferation, Mice, Focal Adhesion Protein-Tyrosine Kinases, Gene Knockdown Techniques, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review